Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:09:59 GMT 2023
by
admin
on
Sat Dec 16 16:09:59 GMT 2023
|
| Protein Type | PEPTIDE |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
MA5AQ51HF3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MA5AQ51HF3
Created by
admin on Sat Dec 16 16:09:59 GMT 2023 , Edited by admin on Sat Dec 16 16:09:59 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR OF AGGREGATION->TARGET |
AβpE is of interest as it has been shown to be one of the dominant forms of Aβ present in the hippocampi and cortices of patients with Alzheimer's disease. However, arguably of most importance is that AβpE is specifically only found within cerebral Aβ plaques.2 In-vitro analysis has revealed that AβpE3 shows an increased rate of aggregation up to 250 times that of full-length Aβ, irrespective of its C terminus.
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
|
|||